Condition (MeSH)
Abducens Nerve Diseases
ClinicalTrials.gov lists 5 trials for Abducens Nerve Diseases or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 5 trials are tagged with Abducens Nerve Diseases itself; the rest are tagged with a narrower condition beneath it.
When did Abducens Nerve Diseases trials start? (5)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2018 | 1 |
| 2017 | 1 |
| 2015 | 1 |
| 2004 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Abducens Nerve Diseases trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 3 |
| Observational | 2 |
How many Abducens Nerve Diseases trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Completed | 1 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Abducens Nerve Diseases? (5)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Botulinum toxin for the treatment of strabismus. | The Cochrane database of systematic reviews | 2017 | Yes |
| Detection of third and sixth cranial nerve palsies with a novel method for eye tracking while watching a short film clip. | Journal of neurosurgery | 2015 | Yes |
| Interventions for eye movement disorders due to acquired brain injury. | The Cochrane database of systematic reviews | 2018 | No |
| Inadvertent intraocular injection of botulinum toxin A. | Journal of pediatric ophthalmology and strabismus | 2011 | No |
| Diplopia following cataract surgery: a review of 150 patients. | Eye (London, England) | 2008 | No |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.